TI
UTHR icon

Telemetry Investments’s United Therapeutics UTHR Stock Holding History

Telemetry Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,306
Closed -$227K – 167
2015
Q2 		$227K Buy
+1,306
New +$235K 0.1% 135

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Telemetry Investments's UTHR Position: Q3 2015 in Review

Telemetry Investments sold out of United Therapeutics (UTHR) in Q3 2015, closing a stake of 1,306 shares — an estimated $227K sold.

Telemetry Investments first reported a position in UTHR in Q2 2015 and held it in 1 quarter. The position peaked at $227K in Q2 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2015.

  • Telemetry Investments reported no remaining United Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Telemetry Investments sold 1,306 United Therapeutics shares in Q3 2015, an estimated $227K.
  • Telemetry Investments first reported a position in United Therapeutics in Q2 2015 and held it in 1 quarter.
  • Telemetry Investments's United Therapeutics position peaked at $227K in Q2 2015.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2015.

Based on Telemetry Investments's 13F filing for Q3 2015, filed 16 Nov 2015.